Patents by Inventor Jennifer A. LO

Jennifer A. LO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING CANCER BY ENHANCING INTRATUMORAL IMMUNE RESPONSE
    Publication number: 20180311505
    Abstract: Provided herein are methods that can be used to produce a local immune response in cancer tissue and/or enhance effectiveness of cancer treatment in a subject through application of one or more combinations of: an ablative fractional laser procedure, a checkpoint inhibitor, and an endosomal TLR agonist (e.g., a TLR3, TLR7, TLR8 or TLR9 agonist).
    Type: Application
    Filed: November 3, 2016
    Publication date: November 1, 2018
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: David E. FISHER, Jennifer A. LO, Dieter MANSTEIN, Masayoshi KAWAKUBO
  • Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20070054896
    Abstract: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: August 14, 2006
    Publication date: March 8, 2007
    Applicant: Wyeth
    Inventors: Hassan Elokdah, Alexander Greenfield, Kevin Liu, Geraldine McFarlane, Cristina Grosanu, Jennifer Lo, Albert Robichaud
  • Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
    Publication number: 20070037802
    Abstract: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: August 14, 2006
    Publication date: February 15, 2007
    Applicant: Wyeth
    Inventors: Hassan Elokdah, Alexander Greenfield, Kevin Liu, Robert McDevitt, Geraldine McFarlane, Cristina Grosanu, Jennifer Lo, Yanfang Li, Albert Robichaud, Ronald Bernotas
  • Isolation and purification of eubacteria and fungus with catalytically inactive murein binding enzymes
    Patent number: 6184027
    Abstract: Catalytically inactive murein binding enzyme diagnostic reagents and methods and kits for detecting eubacteria and fungus in biological samples.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: February 6, 2001
    Assignees: Anomeric, Inc., Board of Supervisors Louisiana State University
    Inventors: Roger A. Laine, Wai Chun.Jennifer Lo
  • Pan-bacterial and pan-fungal identification reagents and methods of use thereof
    Patent number: 6159719
    Abstract: Murein binding polypeptide and antibiotic diagnostic reagents, methods and kits for detecting eubacteria and fungus in biological samples.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: December 12, 2000
    Assignees: Anomeri, Inc., Board of Supervisors Louisiana State University
    Inventors: Roger A. Laine, Wai Chun Jennifer Lo
  • Detecting eubacteria and fungus and determining their antibiotic sensitivity by using catalytically inactive murein binding enzymes
    Patent number: 6090573
    Abstract: A method is presented for detecting eubacteria and fungus in biological samples, and, if present, determining their antibiotic sensitivity, where the presence and amount of eubacteria or fungus is measured by means of catalytically inactive murein binding enzymes in both parts of the method. The sensitivity of eubacteria or fungus to a test antibiotic is obtained by comparing the amount of eubacteria or fungus in the sample after culturing the sample in the presence and absence of the test antibiotic. The biological sample may be chemically treated with alkali to cleave peptide bonds in the sample before incubating the sample with the catalytically inactive murein binding enzyme.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: July 18, 2000
    Inventors: Roger A. Laine, Wai Chun Jennifer Lo